Fennec Pharmaceuticals (FENC) Times Interest Earned (2014 - 2025)
Fennec Pharmaceuticals posted quarterly Times Interest Earned of $7.19 for Q4 2025, up 843.12% year-on-year from $0.76 in Q4 2024, and up 2327.75% on a QoQ basis from -$0.32 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 7 years of Times Interest Earned data on file, last reported at $7.19 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned rose 843.12% year-over-year to $7.19; the trailing twelve-month figure through Dec 2025 stood at -$0.73 (down 215.49% YoY), and the FY2025 full-year result was -$0.73, down 215.41% from the prior year.
- Times Interest Earned for Q4 2025 stood at $7.19, up from -$0.32 in the prior quarter.
- Across five years, Times Interest Earned topped out at $13.29 in Q1 2024 and bottomed at -$1230.8 in Q1 2021.
- The 5-year median for Times Interest Earned is -$5.37 (2023), against an average of -$102.29.
- The widest annual swing landed in 2024, when Times Interest Earned plunged 327.17%; it then surged 843.12% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$67.85 in 2021, then jumped by 87.85% to -$8.25 in 2022, then jumped by 75.9% to -$1.99 in 2023, then soared by 51.34% to -$0.97 in 2024, then jumped by 843.12% to $7.19 in 2025.
- The last three Times Interest Earned figures came in at $7.19 (Q4 2025), -$0.32 (Q3 2025), and -$4.6 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 7.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.19 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -4.60 |
| Mar 31, 2025 | -1.36 |
| Dec 31, 2024 | -0.97 |
| Sep 30, 2024 | -5.08 |
| Jun 30, 2024 | -4.83 |
| Mar 31, 2024 | 13.29 |
| Dec 31, 2023 | -1.99 |
| Sep 30, 2023 | -1.19 |
| Jun 30, 2023 | -5.66 |
| Mar 31, 2023 | -6.60 |
| Dec 31, 2022 | -8.25 |
| Sep 30, 2022 | -66.38 |
| Jun 30, 2022 | -87.88 |
| Mar 31, 2022 | -61.14 |
| Dec 31, 2021 | -67.85 |
| Sep 30, 2021 | -75.87 |
| Jun 30, 2021 | -435.56 |
| Mar 31, 2021 | -1,230.75 |
| Jun 30, 2015 | -54.90 |
| Jun 30, 2014 | -232.50 |